A comparative analysis of changes in IL-17 levels between patients with COPD and ACO revealed that the concentration of this proinflammatory marker in ACOIV was lower (p = 0.016) compared to GOLDIV patients. The gene discussed is IL17A; the disease is chronic obstructive pulmonary disease.